Program in Virology, Graduate School of Arts and Sciences, Harvard University, Cambridge, MA 02138, USA.
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.
Viruses. 2021 Dec 30;14(1):58. doi: 10.3390/v14010058.
Merkel cell polyomavirus (MCV) is the causative agent for the majority of Merkel cell carcinoma (MCC) cases. Polyomavirus-associated MCC (MCCP) is characterized by the integration of MCV DNA into the tumor genome and a low tumor mutational burden. In contrast, nonviral MCC (MCCN) is characterized by a high tumor mutational burden induced by UV damage. Since the discovery of MCV, much work in the field has focused on understanding the molecular mechanisms of oncogenesis driven by the MCV tumor (T) antigens. Here, we review our current understanding of how the activities of large T (LT) and small T (ST) promote MCC oncogenesis in the absence of genomic instability. We highlight how both LT and ST inhibit tumor suppressors to evade growth suppression, an important cancer hallmark. We discuss ST interactions with cellular proteins, with an emphasis on those that contribute to sustaining proliferative signaling. Finally, we examine active areas of research into open questions in the field, including the origin of MCC and mechanisms of viral integration.
Merkel 细胞多瘤病毒 (MCV) 是大多数 Merkel 细胞癌 (MCC) 病例的致病因子。多瘤病毒相关的 Merkel 细胞癌 (MCCP) 的特征是 MCV DNA 整合到肿瘤基因组中,并且肿瘤突变负担较低。相比之下,非病毒 Merkel 细胞癌 (MCCN) 的特征是由 UV 损伤引起的高肿瘤突变负担。自 MCV 发现以来,该领域的大量工作集中于了解由 MCV 肿瘤 (T) 抗原驱动的致癌分子机制。在这里,我们回顾了我们目前对 LT 和 ST 如何在没有基因组不稳定性的情况下促进 MCC 致癌的理解。我们强调了 LT 和 ST 如何抑制肿瘤抑制因子以逃避生长抑制,这是癌症的一个重要标志。我们讨论了 ST 与细胞蛋白的相互作用,重点是那些有助于维持增殖信号的蛋白。最后,我们研究了该领域开放性问题的活跃研究领域,包括 MCC 的起源和病毒整合的机制。